• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤细胞在癌症起始细胞方面的异质性。

Heterogeneity of tumor cells in terms of cancer-initiating cells.

作者信息

Morii Eiichi

机构信息

Department of Pathology, Osaka University Graduate School of Medicine, 2-2 Yamada-oka, Suita, Osaka 565-0871, Japan.

出版信息

J Toxicol Pathol. 2017 Jan;30(1):1-6. doi: 10.1293/tox.2016-0056. Epub 2016 Sep 25.

DOI:10.1293/tox.2016-0056
PMID:28190919
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5293686/
Abstract

Tumors derive from a single cell clone but consist of heterogeneous cell subpopulations with diverse features and functions. A limited number of subclones with a selective advantage can initiate tumors when inoculated into immunocompromised mice, and are called cancer-initiating cells (CICs). CICs can be isolated from the bulk of tumors on the basis of their characteristics, such as high reagent efflux, degradation of reactive oxygen species, and aldehyde dehydrogenase (ALDH) activity. Under normal conditions, new CICs are produced by existing CICs rather than non-CICs. However, under stress conditions, non-CICs can occasionally produce CICs, a phenomenon known as plasticity. The dynamic exchange between CICs and non-CICs may enable tumors to survive under unfavorable conditions. CICs are located in a small portion of tumors. This suggests that microenvironmental factors induce or inhibit the CIC phenotype, which might be regulated by intercellular signaling between tumor cells. This review describes isolation of CICs from tumor cell populations and the microenvironmental factors that regulate CIC phenotypes in uterine cancer and lymphoma.

摘要

肿瘤起源于单个细胞克隆,但由具有不同特征和功能的异质性细胞亚群组成。当接种到免疫缺陷小鼠体内时,少数具有选择性优势的亚克隆可以引发肿瘤,这些亚克隆被称为癌症起始细胞(CICs)。CICs可以根据其特征从大量肿瘤中分离出来,例如高试剂外排、活性氧的降解以及醛脱氢酶(ALDH)活性。在正常情况下,新的CICs是由现有的CICs产生的,而不是由非CICs产生。然而,在应激条件下,非CICs偶尔也可以产生CICs,这种现象被称为可塑性。CICs和非CICs之间的动态交换可能使肿瘤在不利条件下存活。CICs位于肿瘤的一小部分中。这表明微环境因素诱导或抑制CIC表型,这可能由肿瘤细胞之间的细胞间信号传导来调节。本综述描述了从肿瘤细胞群体中分离CICs以及调节子宫癌和淋巴瘤中CIC表型的微环境因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14dc/5293686/0bc1965beed6/tox-30-001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14dc/5293686/22d58a6296eb/tox-30-001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14dc/5293686/0bc1965beed6/tox-30-001-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14dc/5293686/22d58a6296eb/tox-30-001-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/14dc/5293686/0bc1965beed6/tox-30-001-g002.jpg

相似文献

1
Heterogeneity of tumor cells in terms of cancer-initiating cells.肿瘤细胞在癌症起始细胞方面的异质性。
J Toxicol Pathol. 2017 Jan;30(1):1-6. doi: 10.1293/tox.2016-0056. Epub 2016 Sep 25.
2
Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells.霍奇金淋巴瘤细胞中的活性氧和醛脱氢酶活性。
Lab Invest. 2012 Apr;92(4):606-14. doi: 10.1038/labinvest.2012.4. Epub 2012 Feb 20.
3
Establishment and Analysis of Cancer Stem-Like and Non-Cancer Stem-Like Clone Cells from the Human Colon Cancer Cell Line SW480.从人结肠癌细胞系SW480建立癌干细胞样和非癌干细胞样克隆细胞并进行分析。
PLoS One. 2016 Jul 14;11(7):e0158903. doi: 10.1371/journal.pone.0158903. eCollection 2016.
4
Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells.MHC-I 表达的减少限制了 T 淋巴细胞对癌症起始细胞的杀伤作用。
BMC Cancer. 2018 Apr 26;18(1):469. doi: 10.1186/s12885-018-4389-3.
5
Plasma-activated medium (PAM) kills human cancer-initiating cells.等离子体激活介质(PAM)可杀死人类肿瘤起始细胞。
Pathol Int. 2018 Jan;68(1):23-30. doi: 10.1111/pin.12617. Epub 2017 Dec 13.
6
Differential remodeling of extracellular matrices by breast cancer initiating cells.乳腺癌起始细胞对细胞外基质的差异性重塑
J Biophotonics. 2015 Oct;8(10):804-15. doi: 10.1002/jbio.201400079. Epub 2015 Jan 19.
7
Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells.鲁纳辛是一种针对黑色素瘤癌症干细胞的新型治疗药物。
Oncotarget. 2016 Dec 20;7(51):84128-84141. doi: 10.18632/oncotarget.11554.
8
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.癌症起始细胞的免疫调节和免疫抗性特性:对免疫治疗临床成功的意义。
Immunol Invest. 2017 Apr;46(3):221-238. doi: 10.1080/08820139.2017.1280051. Epub 2017 Mar 13.
9
MAPK13 is preferentially expressed in gynecological cancer stem cells and has a role in the tumor-initiation.丝裂原活化蛋白激酶13(MAPK13)在妇科癌症干细胞中优先表达,并在肿瘤起始过程中发挥作用。
Biochem Biophys Res Commun. 2016 Apr 15;472(4):643-7. doi: 10.1016/j.bbrc.2016.03.004. Epub 2016 Mar 9.
10
Targeting the cancer initiating cell: the ultimate target for cancer therapy.针对癌症起始细胞:癌症治疗的终极目标。
Curr Pharm Des. 2012;18(13):1784-95. doi: 10.2174/138161212799859701.

引用本文的文献

1
Single-cell transcriptome analysis upon ECM-remodeling meningioma cells.单细胞转录组分析 ECM 重塑脑膜瘤细胞。
Neurosurg Rev. 2024 Mar 16;47(1):118. doi: 10.1007/s10143-024-02349-5.
2
Knockdown of DEAD-box 51 inhibits tumor growth of esophageal squamous cell carcinoma the PI3K/AKT pathway.敲低 DEAD-box 51 抑制食管鳞癌细胞的生长 通过 PI3K/AKT 通路。
World J Gastroenterol. 2022 Jan 28;28(4):464-478. doi: 10.3748/wjg.v28.i4.464.
3
DDX51 gene promotes proliferation by activating Wnt/β-catenin signaling in breast cancer.

本文引用的文献

1
S100A4 accelerates the proliferation and invasion of endometrioid carcinoma and is associated with the "MELF" pattern.S100A4促进子宫内膜样癌的增殖和侵袭,并与“MELF”模式相关。
Cancer Sci. 2016 Sep;107(9):1345-52. doi: 10.1111/cas.12999. Epub 2016 Aug 12.
2
Self-renewal of tumor cells: epigenetic determinants of the cancer stem cell phenotype.肿瘤细胞的自我更新:癌症干细胞表型的表观遗传决定因素
Curr Opin Genet Dev. 2016 Feb;36:92-9. doi: 10.1016/j.gde.2016.04.002. Epub 2016 May 7.
3
Requirement of CXCL12-CXCR7 signaling for CD20(-) CD138(-) double-negative population in lymphoplasmacytic lymphoma.
DDX51基因通过激活乳腺癌中的Wnt/β-连环蛋白信号通路促进增殖。
Int J Clin Exp Pathol. 2017 Nov 1;10(11):10892-10900. eCollection 2017.
4
Maximum allele frequency observed in plasma: A potential indicator of liquid biopsy sensitivity.血浆中观察到的最大等位基因频率:液体活检敏感性的潜在指标。
Oncol Lett. 2019 Aug;18(2):2118-2124. doi: 10.3892/ol.2019.10490. Epub 2019 Jun 18.
5
Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells.Nanog 信号转导介导 ALDH 阳性乳腺癌细胞的放射抵抗。
Int J Mol Sci. 2019 Mar 6;20(5):1151. doi: 10.3390/ijms20051151.
6
Tumor heterogeneity of gastric cancer: From the perspective of tumor-initiating cell.胃癌的肿瘤异质性:从肿瘤起始细胞的角度看。
World J Gastroenterol. 2018 Jun 28;24(24):2567-2581. doi: 10.3748/wjg.v24.i24.2567.
CXCL12-CXCR7信号通路对淋巴浆细胞淋巴瘤中CD20(-) CD138(-) 双阴性群体的需求
Lab Invest. 2016 May;96(5):517-25. doi: 10.1038/labinvest.2016.28. Epub 2016 Feb 15.
4
MYD88 L265P and CXCR4 mutations in lymphoplasmacytic lymphoma identify cases with high disease activity.淋巴浆细胞淋巴瘤中的 MYD88 L265P 和 CXCR4 突变可识别疾病活动度高的病例。
Br J Haematol. 2015 Jun;169(6):795-803. doi: 10.1111/bjh.13361. Epub 2015 Mar 29.
5
Cancer stem cell plasticity and tumor hierarchy.癌症干细胞可塑性与肿瘤层级结构。
World J Stem Cells. 2015 Jan 26;7(1):27-36. doi: 10.4252/wjsc.v7.i1.27.
6
Microenvironment, tumor cell plasticity, and cancer.微环境、肿瘤细胞可塑性与癌症。
Curr Opin Oncol. 2015 Jan;27(1):64-70. doi: 10.1097/CCO.0000000000000154.
7
Phenotype switching: tumor cell plasticity as a resistance mechanism and target for therapy.表型转换:肿瘤细胞可塑性作为一种耐药机制和治疗靶点。
Cancer Res. 2014 Nov 1;74(21):5937-41. doi: 10.1158/0008-5472.CAN-14-1174. Epub 2014 Oct 15.
8
Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line.组胺在子宫内膜样腺癌细胞系中对醛脱氢酶1表达的作用。
Cancer Med. 2014 Oct;3(5):1126-35. doi: 10.1002/cam4.296. Epub 2014 Jul 10.
9
Discovery and saturation analysis of cancer genes across 21 tumour types.在 21 种肿瘤类型中发现和饱和分析癌症基因。
Nature. 2014 Jan 23;505(7484):495-501. doi: 10.1038/nature12912. Epub 2014 Jan 5.
10
Characterization of subpopulation lacking both B-cell and plasma cell markers in Waldenstrom macroglobulinemia cell line.在华氏巨球蛋白血症细胞系中缺乏 B 细胞和浆细胞标记物的亚群特征。
Lab Invest. 2014 Jan;94(1):79-88. doi: 10.1038/labinvest.2013.129. Epub 2013 Nov 4.